Literature DB >> 16338078

Amphetamine induces dendritic growth in ventral tegmental area dopaminergic neurons in vivo via basic fibroblast growth factor.

D Mueller1, C A Chapman, J Stewart.   

Abstract

Dopaminergic neurons of the ventral tegmental area are implicated in the physiology of reward, and long-lasting changes in their function induced by exposure to psychostimulant drugs are related to the pathophysiology of drug abuse. It is not known, however, whether such changes are accompanied by morphological changes in these neurons. We characterized and labeled cells in slices containing the ventral tegmental area using whole-cell electrophysiological methods. Injections of saline or amphetamine were given to rats on postnatal days 10, 12 and 14 and individual neurons were examined one to four weeks later. We show that repeated exposure to amphetamine induces substantial dendritic growth of ventral tegmental area dopaminergic neurons in vivo. Furthermore, we show, by immuno-neutralization of endogenous basic fibroblast growth factor, that the amphetamine-induced increase in astrocytic basic fibroblast growth factor in the ventral tegmental area is essential for these morphological changes. We propose that the amphetamine-induced elaboration of the dendritic arbor of dopaminergic neurons leads to their increased excitability and contributes to compulsive drug-seeking and relapse.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338078     DOI: 10.1016/j.neuroscience.2005.09.038

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  27 in total

Review 1.  Review. Psychological and neural mechanisms of relapse.

Authors:  Jane Stewart
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

2.  Psychotropic Medications and Their Effect on Brain Volumes in Childhood Psychopathology.

Authors:  Natasha Marrus; Marisa Bell; Joan L Luby
Journal:  Child Adolesc Psychopharmacol News       Date:  2014-04

3.  Blocking Infralimbic Basic Fibroblast Growth Factor (bFGF or FGF2) Facilitates Extinction of Drug Seeking After Cocaine Self-Administration.

Authors:  Madalyn Hafenbreidel; Robert C Twining; Carolynn Rafa Todd; Devin Mueller
Journal:  Neuropsychopharmacology       Date:  2015-05-21       Impact factor: 7.853

4.  Neonatal fibroblast growth factor treatment enhances cocaine sensitization.

Authors:  Sarah M Clinton; Cortney A Turner; Shelly B Flagel; Danielle N Simpson; Stanley J Watson; Huda Akil
Journal:  Pharmacol Biochem Behav       Date:  2012-11       Impact factor: 3.533

5.  Cocaine sensitization inhibits the hyperpolarization-activated cation current Ih and reduces cell size in dopamine neurons of the ventral tegmental area.

Authors:  Francisco Arencibia-Albite; Rafael Vázquez; María C Velásquez-Martinez; Carlos A Jiménez-Rivera
Journal:  J Neurophysiol       Date:  2012-01-18       Impact factor: 2.714

Review 6.  A review of psychostimulant-induced neuroadaptation in developing animals.

Authors:  Normand Carrey; Michael Wilkinson
Journal:  Neurosci Bull       Date:  2011-06       Impact factor: 5.203

7.  Adverse effects of 2,4-dichlorophenoxyacetic acid on rat cerebellar granule cell cultures were attenuated by amphetamine.

Authors:  B Bongiovanni; A Ferri; A Brusco; M Rassetto; L M Lopez; A M Evangelista de Duffard; R Duffard
Journal:  Neurotox Res       Date:  2010-04-10       Impact factor: 3.911

Review 8.  Role of netrin-1 in the organization and function of the mesocorticolimbic dopamine system.

Authors:  Cecilia Flores
Journal:  J Psychiatry Neurosci       Date:  2011-09       Impact factor: 6.186

9.  Regulation of netrin-1 receptors by amphetamine in the adult brain.

Authors:  L Yetnikoff; C Labelle-Dumais; C Flores
Journal:  Neuroscience       Date:  2007-10-10       Impact factor: 3.590

10.  Peri-pubertal emergence of UNC-5 homologue expression by dopamine neurons in rodents.

Authors:  Colleen Manitt; Cassandre Labelle-Dumais; Conrad Eng; Alanna Grant; Andrea Mimee; Thomas Stroh; Cecilia Flores
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.